It's not enough to just talk about clinical trial diversity. Our clinical trial diversity taskforce guides us as we turn data and plans into action. Learn more about the crucial steps we’re taking to make our research truly representative: https://lnkd.in/gfidrm8h #WeWontStop #ViiVScience #ScienceOnTheSofa
ViiV Healthcare
Pharmaceutical Manufacturing
London, England 83,947 followers
We are ViiV Healthcare. Here until HIV & AIDS aren't.
About us
We are ViiV Healthcare: a global specialist HIV company, 100% focused on researching and delivering new medicines and improving access to care for people living with HIV. ViiV Healthcare is an independent company owned by GSK (majority shareholder), Pfizer and Shionogi. To view job opportunities with ViiV Healthcare, please visit the GSK company page: https://www.linkedin.com/company/gsk/jobs Our global headquarters are in Brentford, London UK; with our US headquarters in Research Triangle Park, North Carolina. You can read our Social Media Code of Conduct at: bit.ly/SoMe-VHC
- Website
-
http://www.viivhealthcare.com
External link for ViiV Healthcare
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- London, England
- Type
- Public Company
- Founded
- 2009
- Specialties
- HIV and Pharmaceuticals
Locations
Employees at ViiV Healthcare
Updates
-
📣 Full webinar recording now available! If you missed this impactful session on the power of funding community-driven projects, you can view it on-demand here: https://bit.ly/4gIpdK0
Join us and ETR on December 4 for our next free 3 in 30 webinar, Fueling and Funding Young People to Lead Community Driven Projects. In this conversation, you can expect to hear from micro-grantees of the ViiV Healthcare AMP Grant Initiative, a sustained commitment to community-led organizations that incubate and support emerging projects and leaders to disrupt disparities in HIV care. They will talk specifically about what it means to empower young people to lead projects within their communities. Register for the 3 in 30 webinar here: https://bit.ly/3ASOXnW
-
How do we know when a medicine can be formulated to be longer-acting? The short answer: tireless work in research and development. Learn more about our vision for the future of HIV medicines https://lnkd.in/g8Ra83Ur #WeWontStop #ViiVScience
-
ViiV Healthcare is the only company 100% dedicated to HIV, and our scientists are working tirelessly to develop innovative medicines to help end the #HIV epidemic. Meet our team and hear what excites them most about ViiV’s pipeline. #WeWontStop
-
Over the past 40 years, we’ve made significant progress toward ending the HIV epidemic, but we know we can’t end #HIV alone. Through powerful partnerships with community we are driving scientific innovation, strengthening healthcare systems and tackling stigma, discrimination and misinformation head on 💪 👇Watch the video below to find out more from ViiV and our community partners https://lnkd.in/gjD3NmDP #WeWontStop #EndingHIV
-
Access is critical when it comes to ending the HIV epidemic. We examine strategies and tools to reach the most vulnerable populations in sub-Saharan Africa, Latin America, Asia, and across the world. At ViiV Healthcare, access is a major consideration in our work – including our approach to our clinical trials. Watch #ScienceOnTheSofa to learn more about diversity in clinical trials: https://lnkd.in/gR52Haku #ClinicalTrialDiversity #HealthEquity #ViiVScience
-
En 43 años de historia de VIH, ningún famoso en España ha dicho que tiene VIH. Es más, el 63% de la población cree que no conoce a nadie con VIH, cuando en España una de cada 300 personas tiene VIH. La mayoría de las personas con VIH (más de un 80%) no cuentan públicamente que tienen VIH. Para hacer reflexionar sobre todo esto nace Famoso InVIHsible, una campaña en colaboración con GeSIDA-SEIMC #SEISIDA, CESIDA Coordinadora estatal de VIH y sida y Apoyo Positivo, creada por Sra. Rushmore, que pretende hacer reflexionar sobre el estigma y los prejuicios… por los motivos que hacen que no haya personajes públicos que hayan dicho que tienen VIH. Conoce a Famoso InVIHsible: https://lnkd.in/gvmXxPAK
-
Beaucoup de choses ont changé depuis la découverte du VIH il y a 40 ans. Comme Vinz le souligne, l'une des avancées les plus remarquables dans ce domaine est i=i, indétectable = intransmissible. Pour plus d'infos, regardez la vidéo ou consultez le website www.worldaidsday2024.be #UequalsU #iegali https://lnkd.in/efczhJC7
-
"When we talk about ending the HIV epidemic, we want to make sure we mean that... for EVERYONE." - Dr. Tims-Cook, Atlanta-based infectious disease specialist. Being intentional in the pursuit of representation in clinical research is non-negotiable. Watch the latest #ScienceOnTheSofa to learn how we're building trust and ensuring everyone is represented. Watch now to learn more – https://lnkd.in/gNJTk4hv #WeWontStop #ViiVScience
-
#WeWontStop addressing health disparities across the #US to ensure that all people, regardless of their sexuality, gender or race have equitable access to #HIV treatment and prevention. Find out more from GSK 👇 #EndingHIV
We’re collaborating with community organisations focused on addressing disparities and closing gaps in HIV care. In the US, many Black gay, bisexual, and other men who have sex with men face persistent barriers in accessing HIV prevention, treatment and care. We’re helping to overcome these barriers and ensure equitable access to healthcare for all by supporting community-centred solutions. Hear from Cedric Sturdevant, a dedicated advocate who, with grant funding from ViiV Healthcare (HIV company majority owned by GSK), is driving health equity for members of his community living with HIV in the Mississippi Delta. #HealthEquity 👇